NEW YORK, June 13 (UPI) -- U.S. pharmaceutical company Pfizer Inc. said Monday it gained federal approval for Zmax, a one-dose-only treatment for sinusitis and pneumonia in adults.
Pfizer said Zmax was approved by the Food and Drug Administration for the treatment of mild-to-moderate acute bacterial sinusitis and community acquired pneumonia in adults.
Advertisement
In the first 24 hours after a dose of Zmax, the amount of drug that gets into the tissue is three times higher than a standard dose of immediate-release azithromycin, also known as Zithromax, Pfizer said.
"Results showed that one dose of Zmax was as effective as currently available treatments that must be taken for seven to 10 days," said Dr. Joseph Feczko, chief medical officer at Pfizer.